Read the order, the quantity and the next charge separately

The CoreAge product page describes a starting $114 price for five bottles. Its offer page labels a $114 five-pack as a one-month plan and identifies a total liquid quantity of 10 mL. That establishes the advertised package description. It does not establish how long the supply would last for a particular person or what a clinician would prescribe.

Our CoreAge review keeps the ingredient list and formulation wording attached to that description. A pack count is not a count of guaranteed successful encounters. A reader should not use it to invent a frequency of use, compare injection or tablet amounts, or decide that another product's package represents the same treatment exposure.

The offer says the price stays the same each month while also describing automatic refill as optional after the first order. Those statements can refer to different aspects of the arrangement, but the headline alone does not show what a particular customer has agreed to. An order confirmation and its applicable terms are better records of the charging event than a remembered advertisement.

The FTC's subscription guidance recommends understanding recurring charges, promotional periods and cancellation procedures, and retaining relevant records. This general consumer guidance does not establish CoreAge's specific contract or prove how its billing system operates. Our offer comparison therefore treats public amounts as descriptions with conditions rather than verified personal bills.

CoreAge's offer advertises a free online intake, shipping and ongoing provider access. Its headline says there is no charge unless a provider prescribes, while the footer describes a refund if treatment is not appropriate. That leaves the payment sequence unverified. These are company statements, not outcomes we tested by submitting medical or payment information. They do not establish every possible outside expense, every communication arrangement or all circumstances affecting eligibility.

A useful cost record distinguishes the medicine charge from assessment, follow-up and any separately needed care. If a description leaves an item unresolved, preserve that uncertainty rather than enter zero in a comparison. A free intake is not a guarantee that treatment will be prescribed, and a promise of provider access should not be converted into a guaranteed response time for every medical concern.

Optional recurring delivery is a billing and fulfillment arrangement. It does not remove the need for the clinical team to assess the prescription and respond to changes in health or medicines. Likewise, a patient's wish to cancel a payment arrangement does not provide medical instructions about continuing or changing treatment. Those conversations may involve different contacts and records.

The NIDDK treatment resource describes ED care as addressing underlying causes and selecting appropriate options. Keep that clinical purpose separate from the convenience of an automatic shipment. Neither receiving another package nor renewing a payment establishes that an adverse effect, interaction concern or change in response has been reviewed. A receipt documents a transaction, not a complete clinical assessment.

Providers may advertise per-tablet figures, pack prices or monthly equivalents based on different quantities. A fair financial comparison needs the actual product, supplied amount, billing period and included services. It also needs clarity about initial versus later charges. A low headline cannot be ranked meaningfully when these fields remain unmatched or when the medicine itself is different.

The four-ingredient evidence guide explains why ingredient count cannot establish superior results. The same applies to value: dividing a package price by the number of active ingredients does not reveal value per successful treatment. Published efficacy for another medicine cannot supply a missing success rate for a compounded formula. Costs and clinical evidence must remain separate parts of the record.

Save the dated offer, order confirmation and relevant recurring-payment terms with the invoice. The FTC advises keeping cancellation records and checking subsequent statements when a subscription ends. If a charge differs from the expected amount, those records can help the billing organization identify the issue. They cannot guarantee that a particular dispute will result in a refund.

A cancellation message should identify the financial arrangement it concerns without being treated as advice to alter medicine. Clinical questions belong with the responsible care team. If the company describes several product or plan versions, preserve the name shown on the actual record. A screenshot of a different promotion or a reviewer's previous price may not describe the arrangement being questioned.

Before drawing a conclusion about affordability, list what is known, what is conditional and what has not been verified. Our testimonial guide explains why a satisfied customer's statement about value does not establish another person's bill or medical result. An advertised response window also cannot determine supply duration; see the onset and duration guide.

The ED Offer Review has a commercial connection to CoreAge Rx through its promotional publishing network, and CoreAge receives disclosed first placement. That position does not establish the lowest complete cost or the best clinical choice. The useful outcome is a clear description of the order and its limitations, alongside an independently necessary conversation about suitability and follow-up.